AI Summary
✦ ClarthaValuation Metrics
Trading 43.6% above historical median. Valuation is stable — currently in the strongly overvalued zone (z-score: +1.75). Confidence: 66%.
Live forward EPS implies next-12-month EPS of ₹39.80. Applying the stock's normalized valuation corridor produces a fair range of ₹578.29 to ₹1,112.01, with base value near ₹986.24 (+6.9% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹39.80
Forward P/E
23.2x
Base Fair Value
₹986.24
Fair Range
₹578.29 - ₹1,112.01
Upside To Base
+6.9%
Estimate Source
Live forward EPS
Growth Estimate
+46.7%
5Y Average
19.15
Current
35.59
Overvalued
27.94
Undervalued
14.53
5Y Average
4.83
Current
8.97
Overvalued
6.79
Undervalued
2.88
5Y Average
13.47
Current
25.02
Overvalued
18.93
Undervalued
8.04
Peers & Comparison
Sector: Health Care · Theme: Pharmaceuticals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
AKUMS DRUGS AND PHARMA L AKUMSPharmaceuticals | +9.6% | 5.9% | 43.8x Undervalued | -22% vs avg | +45.4% |
BLUE JET HEALTHCARE LTD BLUEJETPharmaceuticals | -17.4% | 26.5% | 43.7x Undervalued | -23% vs avg | -25.8% |
JEENA SIKHO LIFECARE LTD JSLLPharmaceuticals | +28.8% | 27.8% | 30.3x Undervalued | -46% vs avg | +11.6% |
CAPLIN POINT LAB LTD. CAPLIPOINTPharmaceuticals | +19.0% | 29.3% | 31.2x Undervalued | -45% vs avg | +22.1% |
ALIVUS LIFE SCIENCES LTD ALIVUSPharmaceuticals | +6.4% | 23.3% | 28.0x Undervalued | -50% vs avg | +43.4% |
COHANCE LIFESCIENCES LTD COHANCEPharmaceuticals | -23.1% | 5.0% | 162.0x Premium | +187% vs avg | -52.7% |
SUPRIYA LIFESCIENCE LTD trades at a discount (35.6x vs peer avg 56.5x), suggesting potential undervaluation relative to the Pharmaceuticals cohort. Peers include AKUMS DRUGS AND PHARMA L, BLUE JET HEALTHCARE LTD, JEENA SIKHO LIFECARE LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Financial chart data is not available for this company right now.
Results
Income statement data not available.
All values in ₹ Crores unless otherwise stated. Source: Company filings.